FOLFOXIRI (folinic acid, 5-fluorouracil, oxaliplatin and irinotecan) vs FOLFIR (folinic acid, 5-fluo...
FOLFOXIRI (folinic acid, 5-fluorouracil, oxaliplatin and irinotecan) vs FOLFIR (folinic acid, 5-fluorouracil and irinotecan) as first-line treatment in metastatic colorectal cancer (MCC) : a multicentre randomised phase iii trial from the Hellenic Oncology Research Group (HORG)
About this item
Full title
Author / Creator
SOUGLAKOS, J , ANDROULAKIS, N , KALYKAKI, A , SAMONIS, G , MAVROUDIS, D , GEORGOULIAS, V , SYRIGOS, K , POLYZOS, A , ZIRAS, N , ATHANASIADIS, A , KAKOLYRIS, S , TSOUSIS, S , KOUROUSSIS, Ch and VAMVAKAS, L
Publisher
Basingstoke: Nature Publishing Group
Journal title
Language
English
Formats
Publication information
Publisher
Basingstoke: Nature Publishing Group
Subjects
More information
Alternative Titles
Full title
FOLFOXIRI (folinic acid, 5-fluorouracil, oxaliplatin and irinotecan) vs FOLFIR (folinic acid, 5-fluorouracil and irinotecan) as first-line treatment in metastatic colorectal cancer (MCC) : a multicentre randomised phase iii trial from the Hellenic Oncology Research Group (HORG)
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_pascalfrancis_primary_17642379
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pascalfrancis_primary_17642379
Other Identifiers
ISSN
0007-0920
